Thursday, August 27, 2020 6:29:56 PM
SBFM patent FDA approval covid-19 vaccine and anti cancer drug
Board link:
https://investorshub.advfn.com/Sunshine-Biopharma-Inc-SBFM-14329/
This is showing up on a google search of Sunshine Biopharma SBFM and their recently filed covid-19 patent that was filed on May 22, 2020 along with their FDA application for covid-19.
SBFM Completes Synthesis of Covid-19 Inhibitors Protease! (8/25/20)
https://marketwirenews.com/news-releases/sunshine-biopharma-completes-the-synthesis-of-four-p-4594537033321571.html
SBFM has reduced their OS by 78M confirmed on OTCMarkets!!!
SBFM performed a share buy back in August of 2020 (confirmed on OTCMarkets & most recent 10-Q filing)
That is a 28% reduction in the Outstanding Shares as of 8/19/2020.
DTC registered shares puts the actual available shares at 185M.
From the 10-Q posted 8/19/2020
The number of shares of the registrant’s only class of Common Stock issued and outstanding as of August 18, 2020, was 200,308,644 shares.
https://sec.report/Document/0001654954-20-009340/
https://sec.report/Ticker/SBFM
From OTCMarkets
https://www.otcmarkets.com/stock/SBFM/security
Patent submission was also updated!!
https://brevets-patents.ic.gc.ca/opic-cipo/cpd/eng/patent/2897768/images.html?modificationDate=20200021&page=1&scale=25&rotation=0&frenchDocType=Modification&englishDocType=Amendment&type=basic_search&objectName=A1001001A20H25B03057G27576&numPages=11&query=sunshine+biopharma&start=&num=#archived
The following drugs are available by SBFM:
Anastrozole (brand name Arimidex® by AstraZeneca) for treatment of Breast Cancer
Letrozole (brand name Femara® by Novartis) for treatment of Breast Cancer
Bicalutamide (brand name Casodex® by AstraZeneca) for treatment of Prostate Cancer
Finasteride (brand name Propecia® by Merck) for treatment of BPH (Benign Prostatic Hyperplasia)
Board link:
https://investorshub.advfn.com/Sunshine-Biopharma-Inc-SBFM-14329/
This is showing up on a google search of Sunshine Biopharma SBFM and their recently filed covid-19 patent that was filed on May 22, 2020 along with their FDA application for covid-19.
SBFM Completes Synthesis of Covid-19 Inhibitors Protease! (8/25/20)
https://marketwirenews.com/news-releases/sunshine-biopharma-completes-the-synthesis-of-four-p-4594537033321571.html
SBFM has reduced their OS by 78M confirmed on OTCMarkets!!!
SBFM performed a share buy back in August of 2020 (confirmed on OTCMarkets & most recent 10-Q filing)
That is a 28% reduction in the Outstanding Shares as of 8/19/2020.
DTC registered shares puts the actual available shares at 185M.
From the 10-Q posted 8/19/2020
The number of shares of the registrant’s only class of Common Stock issued and outstanding as of August 18, 2020, was 200,308,644 shares.
https://sec.report/Document/0001654954-20-009340/
https://sec.report/Ticker/SBFM
Market Cap 5,248,086 08/26/2020
Outstanding Shares 200,308,644 08/18/2020
Restricted 11,154 08/04/2020
Unrestricted 278,408,142 08/04/2020
Held at DTC 263,916,517 08/04/2020
From OTCMarkets
https://www.otcmarkets.com/stock/SBFM/security
Patent submission was also updated!!
https://brevets-patents.ic.gc.ca/opic-cipo/cpd/eng/patent/2897768/images.html?modificationDate=20200021&page=1&scale=25&rotation=0&frenchDocType=Modification&englishDocType=Amendment&type=basic_search&objectName=A1001001A20H25B03057G27576&numPages=11&query=sunshine+biopharma&start=&num=#archived
The following drugs are available by SBFM:
Anastrozole (brand name Arimidex® by AstraZeneca) for treatment of Breast Cancer
Letrozole (brand name Femara® by Novartis) for treatment of Breast Cancer
Bicalutamide (brand name Casodex® by AstraZeneca) for treatment of Prostate Cancer
Finasteride (brand name Propecia® by Merck) for treatment of BPH (Benign Prostatic Hyperplasia)
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
